TGFB1 and central nervous system cancer: TGF-β has been reported to enhance the recruitment of regulatory T cells (Treg) in gliomas (Figure 2); interestingly, treatment with an anti-TGF-β antibody, m1D11, diminishes the infiltration of Treg in these tumors [116].